Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546168 · ClinicalTrials.gov registry record · NA
Deviating the Esophagus in Atrial Fibrillation Ablation
A NA study, sponsored by Vivek Reddy.
- Terminated
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT01546168 is a NA study that was terminated before completion, run by Vivek Reddy. The registered enrollment target is 88 participants.
The verdict
NCT01546168, a NA study, was terminated before completion, sponsored by Vivek Reddy.
- TERMINATED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
In this randomized double-blind study, the investigators would like to compare standard practice (i.e., use of luminal esophageal temperature monitoring) to that of esophageal deviation during AF ablation. The investigators hypothesize that the strategy of esophageal deviation will result in safer ablation strategy with a reduction in the incidence of esophageal injury as assessed by endoscopy.
Interventions
- DEVICE esophageal deviation with IDE device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2011-11 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01546168
The ClinicalTrials.gov registry entry for NCT01546168 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vivek Reddy, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which esophageal deviation with IDE device is the first listed.
NCT01546168 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01546168 about?
NCT01546168 is a clinical study titled "Deviating the Esophagus in Atrial Fibrillation Ablation". In this randomized double-blind study, the investigators would like to compare standard practice (i.e., use of luminal esophageal temperature monitoring) to that of esophageal deviation during AF ablation. The investigators hypothesize that the strategy of esophageal deviation will result in safer a...
What is the current status of trial NCT01546168?
This trial is currently terminated. It is a NA study. The enrollment target is 88 participants. The study started on 2011-11. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01546168?
The interventions under investigation include: esophageal deviation with IDE device (DEVICE).
Who is sponsoring clinical trial NCT01546168?
This trial is sponsored by Vivek Reddy, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.